Last reviewed · How we verify

NCT05313503

KETOMIGRAINE: Ketogenic Diet in Drug-resistant Chronic Migraineurs

Status unknown NA Last updated 6 April 2022
What this trial tests

NA trial testing ketogenic diet in Chronic Migraine, Headache in 20 participants. Status unknown.

Timeline
14 January 2022
Primary endpoint
30 January 2023
30 November 2023

Quick facts

Lead sponsorIRCCS National Neurological Institute "C. Mondino" Foundation
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date14 January 2022
Primary completion30 January 2023
Estimated completion30 November 2023
Sites1 location across Italy

Drugs / interventions tested

Conditions studied

Sponsor

IRCCS National Neurological Institute "C. Mondino" Foundation

Who can join

Adults 18 to 65, any sex, with Chronic Migraine, Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Our protocol, named "KETOMIGRAINE", is based on the prescription of a Ketogenic Diet (KD) to twenty subjects with diagnosis of Chronic Migraine (CM), resistant to oral preventive treatments and non-responders to monoclonal antibodies targeting the CGRP pathway. The trial starts with one month of baseline during which are verified inclusion/exclusion criteria. After that, participants will assume KD for three months, a transitional diet (TD) for other three months. Follows a period of three months of free diet (FD). Neurological and dietician visits are scheduled during the course of the trial.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ketogenic diet

Trials testing the same drug.

Other recruiting trials for Chronic Migraine, Headache

Currently open trials in the same condition.

Other IRCCS National Neurological Institute "C. Mondino" Foundation trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05313503.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing